Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Via Supply Disruption — Eugia US LLC (Low Risk — Unli
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Via Supply Disruption — Eugia US LLC (Low Risk — Unli is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Via; Manufacturer: Eugia
| Drug name | Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Via |
|---|---|
| Manufacturer | Eugia US LLC |
| Recall/Disruption reason | Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Ongoing |
| Record type | Enforcement/Recall |
| Recall number | D-0552-2026 |
| Initiation date | 20260518 |
| Quantity affected | 168,300 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →